{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:28:17Z","timestamp":1765826897745},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/qai.0b013e3181a4f00d","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T07:32:57Z","timestamp":1248075177000},"page":"631-639","source":"Crossref","is-referenced-by-count":43,"title":["Quality of Life of Patients With Advanced HIV\/AIDS: Measuring the Impact of Both AIDS-Defining Events and Non-AIDS Serious Adverse Events"],"prefix":"10.1097","volume":"51","author":[{"given":"Aslam H","family":"Anis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne P","family":"Guh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Bansback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilija","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassos C","family":"Kyriakides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Holodniy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D William","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon T","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl 5","key":"R1-18-20210131","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1525-1497.2006.00645.x","article-title":"Patterns of responses on health-related quality of life questionnaires among patients with HIV\/AIDS.","author":"Kudel","year":"2006","journal-title":"J Gen Intern Med"},{"key":"R2-18-20210131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/apc.2005.19.395","article-title":"Predictors of changes in health-related quality of life among men with HIV infection in the HAART era.","volume":"19","author":"Jia","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"R3-18-20210131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/016327879802100207","article-title":"Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients with the human immunodeficiency virus.","volume":"21","author":"Chan","year":"1998","journal-title":"Eval Health Prof"},{"key":"R4-18-20210131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00704430","article-title":"Changes in quality of life among persons with HIV infection.","volume":"1","author":"Lubeck","year":"1992","journal-title":"Qual Life Res"},{"key":"R5-18-20210131","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00002030-199612000-00015","article-title":"Reliability and validity of an HIV-specific health-related quality of life measure for use with injection drug users.","volume":"10","author":"Carretero","year":"1996","journal-title":"AIDS"},{"key":"R6-18-20210131","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1258\/09564620260079608","article-title":"Validation of the Medical Outcomes Study HIV Health Survey as a measure of quality of life in HIV-infected patients in Singapore.","volume":"13","author":"Paton","year":"2002","journal-title":"Int J STD AIDS"},{"key":"R7-18-20210131","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1018451930750","article-title":"Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV).","volume":"6","author":"Wu","year":"1997","journal-title":"Qual Life Res"},{"key":"R8-18-20210131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1015240103565","article-title":"Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial.","volume":"11","author":"Wu","year":"2002","journal-title":"Qual Life Res"},{"key":"R9-18-20210131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1023\/A:1008969512182","article-title":"Economic methods for measuring the quality of life associated with HIV infection.","volume":"8","author":"Bayoumi","year":"1997","journal-title":"Qual Life Res"},{"key":"R10-18-20210131","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM199604183341602","article-title":"Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.","volume":"334","author":"Collier","year":"1996","journal-title":"N Engl J Med"},{"key":"R11-18-20210131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.1997.03540260059037","article-title":"HIV-1 protease inhibitors. A review for clinicians.","volume":"277","author":"Deeks","year":"1997","journal-title":"JAMA"},{"key":"R12-18-20210131","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00126334-200312010-00004","article-title":"Grade 4 events are as important as AIDS events in the era of HAART.","volume":"34","author":"Reisler","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-18-20210131","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjmed.2004.12.034","article-title":"Estimating the proportion of patients infected with HIV who will die of comorbid diseases.","volume":"118","author":"Braithwaite","year":"2005","journal-title":"Am J Med"},{"key":"R14-18-20210131","first-page":"234","article-title":"Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.","volume":"14","author":"Strand","year":"2008","journal-title":"Am J Manag Care"},{"key":"R15-18-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200017010-00002","article-title":"A comparative review of generic quality-of-life instruments.","volume":"17","author":"Coons","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"R16-18-20210131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.300.5.555","article-title":"International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.","volume":"300","author":"Hammer","year":"2008","journal-title":"JAMA"},{"key":"R17-18-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"R18-18-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-116-2-129","article-title":"Quality of life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument.","volume":"116","author":"Wachtel","year":"1992","journal-title":"Ann Intern Med"},{"key":"R19-18-20210131","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1023\/A:1008985728271","article-title":"Health related quality of life among persons with HIV after the use of protease inhibitors.","volume":"9","author":"Low-Beer","year":"2000","journal-title":"Qual Life Res"},{"key":"R20-18-20210131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1008919227665","article-title":"Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study.","volume":"9","author":"Bing","year":"2000","journal-title":"Qual Life Res"},{"key":"R21-18-20210131","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-1-12","article-title":"Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project.","volume":"1","author":"Campsmith","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R22-18-20210131","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1023\/A:1016668802328","article-title":"Health-related quality of life and virologic outcomes in an HIV clinic.","volume":"9","author":"Call","year":"2000","journal-title":"Qual Life Res"},{"key":"R23-18-20210131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005650-200004000-00007","article-title":"Relationship between CD4 counts, viral burden, and quality of life over time in HIV-1-infected patients.","volume":"38","author":"Weinfurt","year":"2000","journal-title":"Med Care"},{"key":"R24-18-20210131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00126334-200208150-00004","article-title":"Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life.","volume":"30","author":"Gill","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-18-20210131","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0197-2456(03)00029-1","article-title":"An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA trial.","volume":"24","author":"Kyriakides","year":"2003","journal-title":"Control Clin Trials"},{"key":"R26-18-20210131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play.","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"key":"R27-18-20210131","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","article-title":"US valuation of the EQ-5D health states: development and testing of the D1 valuation model.","volume":"43","author":"Shaw","year":"2005","journal-title":"Med Care"},{"key":"R28-18-20210131","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00019053-199507060-00005","article-title":"Multi-attribute preference functions. Health Utilities Index.","volume":"7","author":"Torrance","year":"1995","journal-title":"Pharmacoeconomics"},{"key":"R29-18-20210131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","article-title":"Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.","volume":"40","author":"Feeny","year":"2002","journal-title":"Med Care"},{"key":"R30-18-20210131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-1-54","article-title":"The Health Utilities Index (HUI): concepts, measurement properties and applications.","volume":"1","author":"Horsman","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R31-18-20210131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA).","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"issue":"Suppl 9","key":"R33-18-20210131","first-page":"III3","article-title":"Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.","volume":"43","author":"Betz","year":"2005","journal-title":"Med Care"},{"key":"R34-18-20210131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5034\/inquiryjrnl_41.1.95","article-title":"HIV patients in the HCUP Database: a study of hospital utilization and costs.","volume":"41","author":"Hellinger","year":"2004","journal-title":"Inquiry"},{"key":"R35-18-20210131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00005650-200003000-00006","article-title":"Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey.","volume":"38","author":"Grootendorst","year":"2000","journal-title":"Med Care"},{"key":"R36-18-20210131","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.socscimed.2004.08.034","article-title":"A comparison of generic, indirect utility measures (the HUI II, HUI III, SF-6D and EQ-5D) and disease-specific instruments (the RAQoL and HAQ) in rheumatoid arthritis.","volume":"60","author":"Marra","year":"2005","journal-title":"Soc Sci Med"},{"key":"R39-18-20210131","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/01.qai.0000225730.79610.61","article-title":"Predictors for lower quality of life in the HAART era among HIV-infected men.","volume":"42","author":"Liu","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R40-18-20210131","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11136-007-9214-4","article-title":"A further investigation of health related quality of life over time among men with HIV infection in the HAART era.","volume":"16","author":"Huanguang","year":"2007","journal-title":"Qual Life Res"},{"key":"R41-18-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1497.2005.30402.x","article-title":"The association of health-related quality of life with survival among persons with HIV infection in the United States.","volume":"20","author":"Cunningham","year":"2005","journal-title":"J Gen Intern Med"},{"key":"R42-18-20210131","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0895-4356(03)00062-3","article-title":"Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease.","volume":"56","author":"Jacobson","year":"2003","journal-title":"J Clin Epidemiol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200908150-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:24:28Z","timestamp":1618039468000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200908150-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181a4f00d","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}